The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of KRAS mutation variants on clinicopathological features and outcomes in patients with metastatic pancreatic adenocarcinoma.
 
Chirag Patel
No Relationships to Disclose
 
Wei Sha
No Relationships to Disclose
 
Mohamed E. Salem
Consulting or Advisory Role - Bristol-Myers Squibb; Daiichi Sankyo/Astra Zeneca; Exelixis; Exelixis; Merck; Novartis; Pfizer; QED Therapeutics; Taiho Pharmaceutical
Speakers' Bureau - BMS; Daiichi Sankyo/Astra Zeneca; Merck; Pfizer; Taiho Pharmaceutical
 
Laura W. Musselwhite
No Relationships to Disclose
 
Jimmy J. Hwang
Consulting or Advisory Role - Bristol-Myers Squibb; Caris Centers of Excellence; Deciphera; Incyte; Pfizer; QED Therapeutics
Speakers' Bureau - Bristol-Myers Squibb; Deciphera; Incyte
Research Funding - Boehringer Ingelheim (Inst); Caris Centers of Excellence (Inst)
 
Kunal C. Kadakia
No Relationships to Disclose